California Public Employees Retirement System Sells 9,991 Shares of Revvity Inc. $RVTY

California Public Employees Retirement System lessened its stake in Revvity Inc. (NYSE:RVTY) by 4.1% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 233,140 shares of the company’s stock after selling 9,991 shares during the quarter. California Public Employees Retirement System’s holdings in Revvity were worth $20,425,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Tudor Investment Corp ET AL bought a new position in shares of Revvity in the 3rd quarter valued at about $15,128,000. Allspring Global Investments Holdings LLC increased its stake in shares of Revvity by 127.0% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock worth $171,921,000 after purchasing an additional 980,142 shares during the last quarter. SG Americas Securities LLC raised its holdings in shares of Revvity by 186.8% in the 4th quarter. SG Americas Securities LLC now owns 123,173 shares of the company’s stock valued at $11,917,000 after purchasing an additional 80,226 shares during the period. KBC Group NV raised its holdings in shares of Revvity by 115.4% in the 4th quarter. KBC Group NV now owns 39,522 shares of the company’s stock valued at $3,824,000 after purchasing an additional 21,174 shares during the period. Finally, Diamond Hill Capital Management Inc. lifted its stake in Revvity by 6.3% in the 4th quarter. Diamond Hill Capital Management Inc. now owns 426,899 shares of the company’s stock valued at $41,302,000 after purchasing an additional 25,233 shares during the last quarter. 86.65% of the stock is owned by institutional investors.

Revvity Trading Up 0.2%

Shares of RVTY stock opened at $110.78 on Thursday. Revvity Inc. has a 12-month low of $81.22 and a 12-month high of $118.30. The company has a market capitalization of $12.36 billion, a PE ratio of 53.01, a price-to-earnings-growth ratio of 2.17 and a beta of 1.09. The firm has a 50 day moving average price of $104.24 and a two-hundred day moving average price of $99.43. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.37.

Revvity (NYSE:RVTY) last posted its earnings results on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $1.02 by $0.04. The company had revenue of $711.12 million for the quarter, compared to the consensus estimate of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, analysts predict that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be issued a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th. Revvity’s dividend payout ratio is currently 13.40%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on RVTY. Stifel Nicolaus reduced their price target on Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a report on Wednesday, May 6th. Wolfe Research assumed coverage on Revvity in a research note on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Wall Street Zen cut Revvity from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. Robert W. Baird set a $117.00 target price on Revvity in a research note on Wednesday, May 6th. Finally, Weiss Ratings raised Revvity from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. Four analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Revvity currently has a consensus rating of “Hold” and an average target price of $108.92.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.